Gene · 189
Papers3,768
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,768
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Next-generation sequencing in identification of pathogenic variants in primary hyperoxaluria among 21 Egyptian families: Identification of two novel AGXT gene mutations. | Mol Genet Genomic Med | 2022 | 35661454 | PubTator, text mining | PubMed |
| Association between high serum Nogo-B and hypertension in Chinese Han. | BMC Cardiovasc Disord | 2022 | 35655131 | PubTator, text mining | PubMed |
| Whole picture of human stratum corneum ceramides, including the chain-length diversity of long-chain bases. | J Lipid Res | 2022 | 35654151 | PubTator, text mining | PubMed |
| Development of wheat-Dasypyrum villosum T6V#4S·6AL translocation lines with enhanced inheritance for powdery mildew resistance. | Theor Appl Genet | 2022 | 35644815 | PubTator, text mining | PubMed |
| Pathogenic Mechanism of a Highly Virulent Infectious Hematopoietic Necrosis Virus in Head Kidney of Rainbow Trout (Oncorhynchusmykiss) Analyzed by RNA-Seq Transcriptome Profiling. | Viruses | 2022 | 35632602 | PubTator, text mining | PubMed |
| Nuclear mRNA Export and Aging. | Int J Mol Sci | 2022 | 35628261 | PubTator, text mining | PubMed |
| New Insights into the Neuromyogenic Spectrum of a Gain of Function Mutation in SPTLC1. | Genes (Basel) | 2022 | 35627278 | PubTator, text mining | PubMed |
| Cats with Genetic Variants of AGXT2 Respond Differently to a Dietary Intervention Known to Reduce the Risk of Calcium Oxalate Stone Formation. | Genes (Basel) | 2022 | 35627178 | PubTator, text mining | PubMed |
| Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer Cells. | Cancers (Basel) | 2022 | 35625985 | PubTator, text mining | PubMed |
| Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids. | Biomedicines | 2022 | 35625805 | PubTator, text mining | PubMed |
| Alanine-Glyoxylate Aminotransferase Sustains Cancer Stemness Properties through the Upregulation of SOX2 and OCT4 in Hepatocellular Carcinoma Cells. | Biomolecules | 2022 | 35625596 | PubTator, text mining | PubMed |
| Metabolism Dysregulation in Retinal Diseases and Related Therapies. | Antioxidants (Basel) | 2022 | 35624805 | PubTator, text mining | PubMed |
| Genetic testing enables a precision medicine approach for nephrolithiasis and nephrocalcinosis in pediatrics: a single-center cohort. | Mol Genet Genomics | 2022 | 35612621 | PubTator, text mining | PubMed |
Fine-tuning acetyl-CoA carboxylase 1 activity through localization: functional genomics reveals a role for the lysine acetyltransferase NuA4 and sphingolipid metabolism in regulating Acc1 activity and localization. | Genetics | 2022 | 35608294 | PubTator, text mining | PubMed |
| Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome. | JCI Insight | 2022 | 35603787 | PubTator, text mining | PubMed |
| [Prevalence of sleep disturbance in intensive care nurses: a post hoc analysis of a cross-sectional study]. | Zentralbl Arbeitsmed Arbeitsschutz Ergon | 2022 | 35601653 | PubTator, text mining | PubMed |
| Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening. | Front Chem | 2022 | 35601556 | PubTator, text mining | PubMed |
| Neurological update: hereditary neuropathies. | J Neurol | 2022 | 35596796 | PubTator, text mining | PubMed |
| Primary hyperoxaluria: the pediatric nephrologist's point of view. | Clin Kidney J | 2022 | 35592624 | PubTator, text mining | PubMed |
| Primary hyperoxaluria type 1 in developing countries: novel challenges in a new therapeutic era. | Clin Kidney J | 2022 | 35592622 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/189/papers?page=37